Medications for Leukemia Myelocytic Acute

14 results

  • daurismo - glasdegib tablet, film coated

    (Glasdegib)
    Pfizer Laboratories Div Pfizer Inc
    Daurismo, used with low-dose cytarabine, treats newly-diagnosed acute myeloid leukemia (AML) in adults aged 75 or older, or in adults with comorbidities that prevent intensive induction chemotherapy.
    Medication Details
    Savings Programs
    1
    Drug Interactions

  • idhifa - enasidenib mesylate tablet, film coated

    (Enasidenib Mesylate)
    Celgene Corporation
    IDHIFA treats adults with relapsed or refractory acute myeloid leukemia (AML) who have an IDH2 mutation confirmed by an FDA-approved test.
    Medication Details
    Drug Interactions

  • leukine - sargramostim injection, powder, lyophilized, for solution

    (Sargramostim)
    Partner Therapeutics, Inc.
    Leukine is a leukocyte growth factor used to shorten neutrophil recovery after AML chemotherapy in adults 55+, mobilize stem cells for transplant, accelerate myeloid reconstitution after bone marrow or progenitor cell transplantation, treat delayed neutrophil recovery or graft failure, and increase survival after myelosuppressive radiation exposure.
    Medication Details
    Drug Interactions

  • mylotarg - gemtuzumab ozogamicin injection, powder, lyophilized, for solution

    (Gemtuzumab Ozogamicin)
    Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc.
    Mylotarg treats newly-diagnosed CD33-positive acute myeloid leukemia (AML) in adults and pediatric patients 1 month and older, and relapsed or refractory CD33-positive AML in adults and pediatric patients 2 years and older.
    Medication Details
    Drug Interactions

  • neupogen - filgrastim injection, solution

    (Filgrastim)
    Amgen, Inc
    NEUPOGEN is a leukocyte growth factor used to reduce infection risk and neutropenia in cancer patients on chemotherapy or bone marrow transplant, treat AML-related neutropenia, mobilize stem cells for collection, manage severe chronic neutropenia, and improve survival after myelosuppressive radiation exposure.
    Medication Details
    Drug Interactions

  • nivestym - filgrastim - aafi injection, solution

    (Filgrastim-Aafi)
    Pfizer Laboratories Div Pfizer Inc
    Nivestym is a leukocyte growth factor indicated to reduce febrile neutropenia in nonmyeloid malignancy patients on myelosuppressive chemotherapy, shorten neutrophil recovery in AML, reduce neutropenia after bone marrow transplantation, mobilize progenitor cells for leukapheresis, and treat severe chronic neutropenia (congenital, cyclic, or idiopathic).
    Medication Details
    Savings Programs
    1
    Drug Interactions

  • onureg - azacitidine tablet, film coated

    (Azacitidine)
    Celgene Corporation
    Onureg is indicated for continued treatment of adults with acute myeloid leukemia who achieved complete remission after intensive induction chemotherapy and cannot complete intensive curative therapy.
    Medication Details
    Drug Interactions

  • rezlidhia - olutasidenib capsule

    (Olutasidenib)
    Rigel Pharmaceuticals, Inc.
    Rezlidhia treats adult patients with relapsed or refractory acute myeloid leukemia (AML) who have a susceptible IDH1 mutation, as detected by an FDA-approved test.
    Medication Details
    Drug Interactions

  • rydapt - rydapt capsule, liquid filled

    (Rydapt)
    Novartis Pharmaceuticals Corporation
    RYDAPT treats adults with newly diagnosed FLT3 mutation-positive AML in combination with chemotherapy (not as single-agent induction), and adults with aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), or mast cell leukemia (MCL).
    Medication Details
    Drug Interactions

  • tibsovo - ivosidenib tablet, film coated

    (Ivosidenib)
    Servier Pharmaceutical Llc
    Tibsovo is an IDH1 inhibitor for adults with susceptible IDH1 mutations. Indicated for newly diagnosed AML in patients 75+ or unfit for intensive chemotherapy, relapsed or refractory AML, relapsed or refractory myelodysplastic syndromes, and previously treated locally advanced or metastatic cholangiocarcinoma.
    Medication Details
    Drug Interactions